**Core Concept:** Paroxysmal Supraventricular Tachycardia (PSVT) is a type of supraventricular tachycardia, characterized by rapid heartbeats (tachycardia) originating from the atria or atrioventricular node (AVNRT, AVRT, or atrioventricular nodal reentrant tachycardia).

**Why the Correct Answer is Right:**

The correct answer, **D:** **Esmolol**, is a short-acting beta-adrenergic antagonist used to treat PSVT. It works by blocking beta-1 receptors on atrial myocardium, reducing automaticity and conduction velocity, causing a decrease in atrial rate and ultimately reverting the tachycardia to normal sinus rhythm.

**Why Each Wrong Option is Incorrect:**

A. **Propafenone:** This is a class Ic antiarrhythmic agent used for the treatment of PSVT. However, it is a broad-spectrum agent that blocks both beta-1 and beta-2 receptors, which may lead to unwanted side effects like bradycardia, hypotension, and worsening of heart failure.

B. **Ibuprofen:** Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used for pain relief and inflammation. It does not have any direct action on the heart to treat PSVT.

C. **Calcium channel blockers:** These are mainly used to treat hypertension and angina but have no direct effect on the heart rhythm. They may even worsen PSVT by reducing vagal tone and increasing sympathetic activity.

**Clinical Pearl:** When treating PSVT, it is essential to consider the patient's clinical condition and comorbidities while choosing the appropriate medication. In the case of PSVT, beta-blockers like esmolol are preferred over calcium channel blockers or NSAIDs like ibuprofen due to their direct effect on the heart. In contrast, propafenone can be considered in carefully selected cases where the risk-benefit ratio is favorable, especially if the patient has no contraindications or comorbidities like heart failure or severe bradycardia.